Skip to content
healthcare.dev

MARPLAN

NDC 72336-032, isocarboxazid, tablet, from Lifsa Drugs LLC.

Product NDC
72336-032
Status
Listed
Labeler
Lifsa Drugs LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA011961
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72336-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ISOCARBOXAZID10 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
72336-032-0172336003201100 TABLET in 1 BOTTLE, PLASTIC (72336-032-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/95fde749-44ad-4668-86c4-0ff17bca0074

Use it

Look up 72336-032 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72336-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72336-032. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.